Literature DB >> 17545516

Insulin-like growth factor-I produced by seminal vesicles: relationship to intraepithelial basal cell hyperplasia in the prostate.

Fernando U Garcia1, Katarzyna Urbanska, Lauren Koltowski, Krzysztof Reiss, Christian Sell.   

Abstract

PURPOSE: This study examined the seminal vesicle fluid (SVF) as a potential local source of insulin-like growth factor-I (IGF-I) in the peripheral zone of the prostate. EXPERIMENTAL
DESIGN: IGF-I levels in seminal fluid were measured. The levels of the IGF-I receptor (IGF-IR) in its active, phosphorylated form as well as direct downstream targets were examined in the peripheral zone of the prostate.
RESULTS: In situ, we find that the IGF-IR is activated in the peripheral zone in areas of atrophy, prostatic intraepithelial hyperplasia, and cancer. In addition, immunostaining reveals preferential activation of the IGF-IR in p63-positive cells in areas of intermediate basal cell hyperplasia in the peripheral zone, indicating that prostate progenitor cells are highly sensitive to increases in local IGF-I levels. These areas of basal cell hyperplasia occur at high incidence in the peripheral zone of the prostate. Relatively high levels of IGF-I were identified in SVF. In addition, we find that SVF can stimulate the proliferation of both normal and cancer-derived prostate cells.
CONCLUSIONS: These results suggest that SVF is a local source of IGF-I that provides chronic stimulation of prostate cells. This chronic stimulation could contribute to the development of prostate cancer in older men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545516     DOI: 10.1158/1078-0432.CCR-06-2607

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  2 in total

1.  Nutrition regulation of male accessory gland growth and maturation in Tribolium castaneum.

Authors:  Jingjing Xu; Ashlee L Anciro; Subba Reddy Palli
Journal:  Sci Rep       Date:  2015-06-02       Impact factor: 4.379

2.  Down-regulation of osteopontin attenuates breast tumour progression in vivo.

Authors:  Goutam Chakraborty; Shalini Jain; Tushar V Patil; Gopal C Kundu
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.